Year: 2021

Aehr Test Systems Joins PowerAmerica Institute to Support Advancing SiC and GaN Technologies for Next Generation Power Electronics and Electric Vehicles

Written by Customer Service on November 18, 2021. Posted in Public Companies.

FREMONT, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — Aehr Test Systems (NASDAQ: AEHR), a worldwide supplier of semiconductor test and reliability qualification equipment, is pleased to announce today that it has joined the PowerAmerica Institute (PowerAmerica), a public-private research initiative dedicated to accelerating the adoption of high performing, next generation silicon carbide (SiC) and gallium nitride (GaN) power electronics. The collaboration will result in bringing next generation silicon carbide and gallium nitride power electronics to markets faster, reducing cost and risk factors associated with new generation technologies. An organization that brings together the semiconductor manufacturers and the companies that use semiconductor power electronics in their products, PowerAmerica Institute is well placed as an information...

Verrica Pharmaceuticals Announces FDA Acceptance of its IND Application for LTX-315, a Potential First-in-Class Oncolytic Peptide-Based Immunotherapy, for the Treatment of Basal Cell Carcinoma

Written by Customer Service on November 18, 2021. Posted in Public Companies.

Company expects to initiate Phase 2 trial in basal cell carcinoma in 1Q 2022 Non-melanoma skin cancers are the most common form of cancer in the U.S., with over 5 million diagnoses each year WEST CHESTER, Pa., Nov. 18, 2021 (GLOBE NEWSWIRE) — Verrica Pharmaceuticals Inc. (“Verrica”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring medical interventions, today announced that the U.S. Food and Drug Administration (“FDA”) has accepted the Company’s Investigational New Drug Application (“IND”) for LTX-315, a potential first-in-class oncolytic peptide, for the treatment of basal cell carcinoma. The Company expects to initiate its Phase 2 trial of LTX-315 in basal cell carcinoma in the first quarter of 2022. “We are excited to bring this novel immunotherapy to the clinic as a potential...

BridgeBio Pharma, Inc. Secures Up to $750 Million in Non-Dilutive Debt Financing

Written by Customer Service on November 18, 2021. Posted in Public Companies.

-Innovative financing facility and existing cash balance gives BridgeBio access to over $1.2 billion, which is expected to fully fund the Company’s 30+ genetic disease and cancer pipeline programs into 2024 PALO ALTO, Calif., Nov. 18, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio or the Company), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, today announced that it has executed a definitive credit facility agreement with a syndicate of lenders for up to $750.0 million in financing. This facility, combined with the Company’s existing cash balance as of September 30, 2021, provides access to over $1.2 billion to advance the Company’s pipeline programs, support commercialization efforts, and enable the Company to pursue strategic business development opportunities....

Monro, Inc. To Present at Stephens Annual Investment Conference

Written by Customer Service on November 18, 2021. Posted in Public Companies.

ROCHESTER, N.Y., Nov. 18, 2021 (GLOBE NEWSWIRE) — Monro, Inc. (Nasdaq: MNRO), a leading provider of automotive undercar repair and tire services, today announced that Mike Broderick, President and Chief Executive Officer, and Brian D’Ambrosia, Executive Vice President and Chief Financial Officer, will present at the Stephens Annual Investment Conference. The company’s presentation is scheduled for Thursday, December 2, 2021 at 3:00 PM CT. A live webcast of the event will be available via the “Investors” section of the Company’s Corporate website (corporate.monro.com), or at the following link (http://wsw.com/webcast/stph32/mnro/). The webcast will be archived for 90 days. About Monro, Inc. Monro, Inc. (NASDAQ: MNRO) is one of the nation’s leading automotive service and tire providers, delivering best-in-class auto care to communities...

Q3 2021 Interim Report and Investor Conference Call Announcement

Written by Customer Service on November 18, 2021. Posted in Earnings Releases And Operating Results.

November 18th2021 Q3 2021 Interim Report and Investor Conference Call Announcement Welltec® will disclose its Q3 2021 Interim Report and will discuss the results during an investor conference call to be held Thursday, November 25th 2021 at 5 pm CET. The conference call will be available only for current and prospective bond holders, broker dealers and securities analysts and can be accessed by dialing in a few minutes before the start and informing the operator that you would like to participate in Welltec’s investor conference call. Relevant dial-in details and conference ID can be obtained by contacting Mads Brixtofte Rasmussen mbrasmussen@welltec.com and registering for the call. Registration will not be possible once the investor conference has started. The Q3 2021 Interim Report will be made available in the “Investor Room” on Welltec’s...

Claritas Provides Update Regarding Phase 1 Clinical Study

Written by Customer Service on November 18, 2021. Posted in Public Companies.

SAN FRANCISCO and TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) — Claritas Pharmaceuticals, Inc. (TSX VENTURE: CLAS and OTC: KALTF) (the “Company” or “Claritas“) today provided an update regarding the expected time to completion of its Phase 1 clinical study of R-107, the Company’s proprietary, liquid, nitric oxide-releasing compound (the “Phase 1 Study”). Phase 1 Study to be Completed at Scientia Clinical Research Claritas is focused on completing the Phase 1 Study as quickly as possible. Due to the inability of CMAX Clinical Research (“CMAX”) to provide an assurance that the Phase 1 Study will be completed during Q1 2022, Claritas has terminated its agreement with CMAX, and has entered into a Clinical Trial Research Agreement with Scientia Clinical Research (“Scientia”), a state-of-the-art clinical trials facility...

Major Drilling to Release Second Quarter Results for Fiscal 2022

Written by Customer Service on November 18, 2021. Posted in Public Companies.

Management to Conduct Webcast/Conference Call on Friday, December 3, 2021 at 9:00am EST MONCTON, New Brunswick, Nov. 18, 2021 (GLOBE NEWSWIRE) — Major Drilling Group International Inc. (TSX: MDI) (the “Company”) today reported that it will release its second quarter results, ended October 31, 2021, on Thursday, December 2, 2021 after the markets have closed. Webcast/Conference Call Details Denis Larocque, President & Chief Executive Officer, and Ian Ross, Chief Financial Officer, invite you to participate in a webcast/conference call on Friday, December 3, 2021 at 9:00 a.m. Eastern to discuss the Company’s second quarter results for fiscal 2022. To access the webcast, which includes a slide presentation, please go to the investors/webcasts section of the Major Drilling website at www.majordrilling.com and click on the link....

Big Data as a Service (BDaaS) Market to Exhibit 28.2% CAGR by 2028; Rapid Adoption by Social Media Platforms to Bolster Growth, says Fortune Business Insights™

Written by Customer Service on November 18, 2021. Posted in Mergers And Acquisitions.

Companies Profiled in the Market: Wipro Limited, Zero Stack, Inc., Accenture Plc., SAP SE, Oracle Corporation, Microsoft Corporation, CenturyLink, Inc., IBM Corporation, Hewlett Packard Enterprise, Amazon Web Services, Inc. Pune, India, Nov. 18, 2021 (GLOBE NEWSWIRE) — The global big data as a service (BDaaS) market size is expected to showcase significant growth by reaching USD 93.52 Billion by 2028. This is attributable to the rapid adoption of big data as a service by social media platforms, coupled with the growing e-commerce industry worldwide. According to a recent report by Fortune Business Insights, titled, “Big Data as a Service (BDaaS) Market Size, Share & COVID-19 Impact Analysis, By Solution (Hadoop-as-a-Service, Data-as-a-Service, and Data Analytics-as-a-Service), By Deployment Model (Public Cloud, Private Cloud...

Sun Country Airlines and Caesars Entertainment Announce New Five-Year Charter Agreement

Written by Customer Service on November 18, 2021. Posted in Public Companies.

Sun Country Airlines to provide two aircraft to support Caesars Entertainment’s charter needs in key destinations including Reno/South Lake Tahoe, Laughlin, Atlantic City and Gulfport, Miss. MINNEAPOLIS, Nov. 18, 2021 (GLOBE NEWSWIRE) — Sun Country Airlines (NASDAQ: SNCY) today announced a new five-year agreement to provide charter service to Caesars Entertainment, Inc. This agreement restarts a relationship between the two organizations that ended in late 2020. The new partnership begins in March 2022 and will be fully ramped up in the second quarter of 2022. Additionally, the agreement calls for two aircraft to provide charter service for Caesars Entertainment guests. The initial aircraft will be based in Laughlin, Nev. and Gulfport, Miss. The contract also allows for additional aircraft to be added, as needed, to meet the growing...

Guardian Capital Group Limited Renews Normal Course Issuer Bid

Written by Customer Service on November 18, 2021. Posted in Public Companies.

TORONTO, Nov. 18, 2021 (GLOBE NEWSWIRE) — Guardian Capital Group Limited (“Guardian”) (TSX:GCG) (TSX:GCG.A) announced today that it has received approval from the Toronto Stock Exchange (“TSX”) for its Normal Course Issuer Bid, pursuant to which it intends to purchase, during the period from November 23, 2021 to November 22, 2022, up to 137,469 or 5% of its outstanding Common Shares, entitled to one vote per share, and up to 1,706,357 or 10% of its public float of Non-Voting Class A Shares (“Class A Shares”) as at November 9, 2021. Shares may also be purchased by the trustee (the “Trustee”) for Guardian’s employee profit sharing plan. In each case, these shares will be purchased at market prices, on the TSX and alternative Canadian trading systems. All shares purchased by Guardian (but not those purchased by the Trustee) will be...

Year: 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals